Federal Health Grants

The purpose of this notice of funding opportunity (NOFO) is to support radiation research at all stages of development for the identification of biomarkers of injury and the development of assays or devices for the purpose of triage, including assessing absorbed dose or predicting health outcomes of acute or delayed injuries resulting from radiation exposure during a public health emergency. This NOFO will support the development of these approaches, with the goal of future regulatory approval. The focus of this NOFO is the development and validation of rapid, reliable, inexpensive, and easy-to-use techniques/assays and devices for use in all segments of the civilian population including geriatric, pediatric, and immune-compromised individuals. Thus, research activities ranging from immediate, early, and delayed changes in radiation-related biomarkers, studies exploring the biokinetics of the proposed biomarker signature, and studies to predict the acute or chronic health outcome in one or more organs are requested. The selection of radiation exposure type, dose level, and dose rates proposed for studies should be relevant to a radiological or nuclear incident and verified by appropriate dosimetry assessments. The ideal radiation signature will be measurable in a non-invasive or minimally invasive way (e.g., finger stick, urine, saliva, or skin scraping as opposed to spinal fluid or complex imaging) that will allow for repeated assays over time, is sensitive to incremental differences in radiation exposure, is specific over a wide range of radiation doses and dose rates and has utility for different qualities of radiation (high and low linear energy transfer).

USAID Bureau for Global Healths (GH) Office of Population and Reproductive Health (PRH) will implement the Accelerating ChoiCe, Equity, and Sustainability for Services (ACCESS) award, which aims to improve SRH and related health outcomes among individuals across the life course. The award will reach underserved populations, with a particular focus on those who face the greatest inequities in FP/RH service delivery, including adolescents/youth and other marginalized groups, such as persons with disabilities, Indigenous Peoples, racial and ethnic minorities, persons living in extreme poverty, and LGBTQI+ personsmany of whom have intersecting identities.

This funding opportunity is designed to support small businesses in developing innovative technologies that address social needs impacting substance use disorders, with a focus on improving access to care and reducing barriers for at-risk individuals.

This funding opportunity provides financial support to various organizations working in Kenya to strengthen health systems and improve access to HIV and tuberculosis diagnostic and treatment services.

This funding opportunity supports researchers exploring the use of microorganisms for innovative cancer therapies and imaging techniques, particularly in areas where traditional treatments fall short.

This funding opportunity provides financial support to state and local health agencies to improve early hearing detection and intervention systems, ensuring timely diagnosis and services for infants who are deaf or hard of hearing.

This funding opportunity supports research aimed at improving drug safety and effectiveness for pregnant women, breastfeeding mothers, and children, encouraging innovative studies that address their unique health needs.

This funding opportunity provides access to a specialized facility for researchers developing innovative, safe, and effective non-hormonal contraceptive methods for men and women, supporting preclinical studies necessary for future clinical trials.

This funding opportunity provides financial support for under-resourced U.S. institutions to acquire advanced scientific instruments that enhance biomedical research and education, particularly for students from diverse and underserved backgrounds.

FY 2024 Natural Gas Distribution Infrastructure Safety and Modernization Grant

The Office of National Drug Control Policy (ONDCP), Executive Office of the President, is seeking applications from a non-profit entity as described in Section 501(c)(3) of the Internal Revenue Code with expert knowledge and extensive experience in: (1) Supporting the development and implementation of local pilot projects to reduce overdose and related harms for individuals interacting with first responders and the criminal justice system; and (2) Working collaboratively with multi-sector partners and people with lived and living experience to innovative strategies at the intersection of public health and public safety that focus on saving lives and reducing harm.

This program provides financial support to individuals who become living organ donors, helping cover costs like lost wages, transportation, and care for dependents, particularly for those from underserved communities.

This funding opportunity supports research collaborations between academic institutions and community behavioral health organizations to improve outpatient mental health and substance use treatment through evidence-based practices.

This funding opportunity supports innovative research projects that aim to reduce health disparities and promote health equity in diverse populations across the United States.

The "Ending the HIV Epidemic in the U.S. Systems Coordination Provider" grant aims to fund technical assistance and systems coordination in specific U.S. jurisdictions to reduce new HIV infections by diagnosing, treating, preventing, and responding to HIV outbreaks, while also encouraging innovative approaches and coordination of resources to maximize the impact of HIV care delivery systems.

This funding opportunity provides financial support to organizations looking to establish or expand comprehensive healthcare services for elderly individuals in underserved rural areas.

This funding opportunity supports small research teams in developing innovative biomedical technologies that address critical health challenges and improve healthcare accessibility.

This program will support projects to identify and characterize factors associated with gender-affirming hormone therapy (GAHT) that may impact/contribute significantly to the prevention and treatment of HIV and/or co-infections with other sexually transmitted infections (STI)s in transgender individuals. For this funding opportunity GAHT is defined as a medical intervention, including but not limited to estrogen and/or testosterone treatment, that results in acquisition of secondary sex characteristics that align with an individual's gender identity. A growing body of data indicates that GAHT may impact the effectiveness and implementation of biomedical HIV prevention or treatment strategies and/or co-infections with other STIs. A number of factors in transgender populations present research challenges including variability in GAHT regimens, use of auxiliary drugs during GAHT care, access to participants, and access to existing cohorts, datasets, and samples. Consideration of appropriate controls, including cis-gender men and women is also a barrier. Recent studies demonstrating recruitment and retention of participants undergoing GAHT provide the opportunity to build on those studies and provide confidence that these critical studies are feasible.Letter of Intent Due Date(s) 30 days prior to the application due date

The Preventive Health and Health Services (PHHS) Block Grant Program allows recipients to address their own unique public health needs and challenges with innovative and community-driven methods. Recipients set their own goals and program objectives and implement local strategies to address Healthy People 2030 priorities.

This funding opportunity supports research centers focused on improving maternal and child health outcomes through innovative studies and partnerships, particularly addressing disparities and critical health challenges.